- Home
- DGX vs MKL Comparison
DGX vs MKL Comparison
Compare DGX & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- MKL
- Stock Information
- Founded
- DGX 1967
- MKL 1930
- Country
- DGX United States
- MKL United States
- Employees
- DGX N/A
- MKL N/A
- Industry
- DGX Medical Specialities
- MKL Property-Casualty Insurers
- Sector
- DGX Health Care
- MKL Finance
- Exchange
- DGX Nasdaq
- MKL Nasdaq
- Market Cap
- DGX 20.5B
- MKL 24.4B
- IPO Year
- DGX 1996
- MKL 1986
- Fundamental
- Price
- DGX $189.25
- MKL $2,090.71
- Analyst Decision
- DGX Buy
- MKL Hold
- Analyst Count
- DGX 15
- MKL 2
- Target Price
- DGX $194.07
- MKL $1,930.50
- AVG Volume (30 Days)
- DGX 1.2M
- MKL 42.1K
- Earning Date
- DGX 10-21-2025
- MKL 10-29-2025
- Dividend Yield
- DGX 1.71%
- MKL N/A
- EPS Growth
- DGX 14.49
- MKL N/A
- EPS
- DGX 8.51
- MKL 142.27
- Revenue
- DGX $10,850,000,000.00
- MKL $16,210,307,000.00
- Revenue This Year
- DGX $12.37
- MKL N/A
- Revenue Next Year
- DGX $3.51
- MKL $0.39
- P/E Ratio
- DGX $22.03
- MKL $14.66
- Revenue Growth
- DGX 13.74
- MKL N/A
- 52 Week Low
- DGX $148.70
- MKL $1,621.89
- 52 Week High
- DGX $197.55
- MKL $2,109.91
- Technical
- Relative Strength Index (RSI)
- DGX 61.52
- MKL 70.79
- Support Level
- DGX $175.77
- MKL $1,943.75
- Resistance Level
- DGX $191.31
- MKL $1,976.79
- Average True Range (ATR)
- DGX 4.20
- MKL 36.72
- MACD
- DGX 1.20
- MKL 18.92
- Stochastic Oscillator
- DGX 85.13
- MKL 92.70
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About MKL Markel Group Inc.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.